ABUS vs DDOG · P/E 5.4, rev $6.2M vs P/E 292, rev $3.43B
Arbutus Biopharma Corp (ABUS) versus Datadog Inc (DDOG) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Datadog Inc (DDOG) is a software - application company listed on US. It is led by Olivier Pomel.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported DDOG revenue for 2025-12-31 was $3.43B. Net income was $107.7M. Revenue was up 27.7% from 2024-12-31 to 2025-12-31. DDOG currently screens at market cap $47.44B and trailing P/E 292.3.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. DDOG currently screens at market cap $47.44B and trailing P/E 292.3.
Not investment advice. Open the ABUS and DDOG stock pages for the full models.
Not investment advice.